| Year |
Title |
Altmetric |
| 2020
|
Runx2 deficiency in osteoblasts promotes myeloma progression by altering the bone microenvironment at new bone sites.
Cancer Research.
80:1036-1048.
2020
|
|
| 2018
|
Angiogenic and Osteogenic Synergy of Human Mesenchymal Stem Cells and Human Umbilical Vein Endothelial Cells Cocultured on a Nanomatrix.
Scientific Reports.
8.
2018
|
|
| 2018
|
Epigenetic remodeling and modification to preserve skeletogenesis in vivo.
Connective Tissue Research.
59:52-54.
2018
|
|
| 2018
|
Specificity Protein 7 Is Required for Proliferation and Differentiation of Ameloblasts and Odontoblasts.
Journal of Bone and Mineral Research.
33:1126-1140.
2018
|
|
| 2017
|
Dwarfism in homozygous Agc1CreERT mice is associated with decreased expression of aggrecan
2017
|
|
| 2016
|
Transcriptional auto-regulation of RUNX1 P1 promoter.
PLoS ONE.
11.
2016
|
|
| 2016
|
Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cells.
Oncotarget.
7:11299-11309.
2016
|
|
| 2015
|
Loss of Runx2 in committed osteoblasts impairs postnatal skeletogenesis.
Journal of Bone and Mineral Research.
30:71-82.
2015
|
|
| 2015
|
MicroRNA 665 regulates dentinogenesis through microRNA-mediated silencing and epigenetic mechanisms.
Molecular and Cellular Biology.
35:3116-3130.
2015
|
|
| 2015
|
Myeloma cell-derived Runx2 promotes myeloma progression in bone.
Blood.
125:3598-3608.
2015
|
|
| 2014
|
Runx2 regulates endochondral ossification through control of chondrocyte proliferation and differentiation.
Journal of Bone and Mineral Research.
29:2653-2665.
2014
|
|
| 2014
|
Runx2 activity in committed osteoblasts is not essential for embryonic skeletogenesis.
Connective Tissue Research.
55:102-106.
2014
|
|
| 2014
|
Sp7 and Runx2 molecular complex synergistically regulate expression of target genes.
Connective Tissue Research.
55:83-87.
2014
|
|
| 2014
|
Specificity protein 7 is not essential for tooth morphogenesis.
Connective Tissue Research.
55:88-91.
2014
|
|
| 2013
|
Breakpoint regions of ETO gene involved in (8; 21) leukemic translocations are enriched in acetylated histone H3.
Journal of Cellular Biochemistry.
114:2569-2576.
2013
|
|
| 2013
|
Heparanase inhibits osteoblastogenesis and shifts bone marrow progenitor cell fate in myeloma bone disease.
BONE.
57:10-17.
2013
|
|
| 2012
|
Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification.
Circulation Research.
111:543-552.
2012
|
|
| 2011
|
Biphasic peptide amphiphile nanomatrix embedded with hydroxyapatite nanoparticles for stimulated osteoinductive response.
ACS Nano.
5:9463-9479.
2011
|
|
| 2011
|
Effect of sodium hypochlorite on human pulp cells: An in vitro study
2011
|
|
| 2011
|
Chondrocyte-specific regulatory activity of Runx2 is essential for survival and skeletal development
2011
|
|
| 2011
|
Runx2 regulates the gene network associated with insulin signaling and energy homeostasis
2011
|
|
| 2011
|
Osteogenic differentiation of human mesenchymal stem cells synergistically enhanced by biomimetic peptide amphiphiles combined with conditioned medium.
Acta Biomaterialia.
7:675-682.
2011
|
|
| 2010
|
Subnuclear localization and intranuclear trafficking of transcription factors..
Methods in Molecular Biology.
647:77-93.
2010
|
|
| 2010
|
Genetic and Transcriptional Control of Bone Formation.
Oral and Maxillofacial Surgery Clinics of North America.
22:283-293.
2010
|
|
| 2010
|
Definitive hematopoiesis requires Runx1 C-terminal-mediated subnuclear targeting and transactivation.
Human Molecular Genetics.
19:1048-1057.
2010
|
|
| 2010
|
Subnuclear localization and intranuclear trafficking of transcription factors.
Methods in Molecular Biology.
647:77-93.
2010
|
|
| 2009
|
Identification of Potential Enhancers in the RUNX1 Gene.
The FASEB Journal.
23.
2009
|
|
| 2009
|
Altered chromatin modifications in AML1/RUNX1 breakpoint regions involved in (8;21) translocation.
Journal of Cellular Physiology.
218:343-349.
2009
|
|
| 2009
|
Transcription-factor-mediated epigenetic control of cell fate and lineage commitment.
Biochemistry and Cell Biology.
87:1-6.
2009
|
|
| 2009
|
A Runx2 threshold for the cleidocranial dysplasia phenotype.
Human Molecular Genetics.
18:556-568.
2009
|
|
| 2009
|
Organization, integration, and assembly of genetic and epigenetic regulatory machinery in nuclear microenvironments: Implications for biological control in cancer.
Annals of the New York Academy of Sciences.
1155:4-14.
2009
|
|
| 2008
|
Specific residues of RUNX2 are obligatory for formation of BMP2-induced RUNX2-SMAD complex to promote osteoblast differentiation
2008
|
|
| 2008
|
Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitors.
Journal of Biological Chemistry.
283:27585-27597.
2008
|
|
| 2008
|
A Runx2 Threshold for the Cleidocranial Dysplasia Phenotype..
Journal of Bone and Mineral Research.
23:S384-S384.
2008
|
|
| 2008
|
Induction of Runx2 and Osterix by Bisphosphonate Promote Osteogenic Differentiation.
Journal of Bone and Mineral Research.
23:S257-S257.
2008
|
|
| 2008
|
Genetic and epigenetic regulation in nuclear microenvironments for biological control in cancer.
Journal of Cellular Biochemistry.
104:2016-2026.
2008
|
|
| 2008
|
Chromatin immunoprecipitation assays: application of ChIP-on-chip for defining dynamic transcriptional mechanisms in bone cells..
Methods in Molecular Biology.
455:165-176.
2008
|
|
| 2008
|
In situ nuclear organization of regulatory machinery..
Methods in Molecular Biology.
455:239-259.
2008
|
|
| 2008
|
Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling.
Journal of Biological Chemistry.
283:15319-15327.
2008
|
|
| 2008
|
Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal.
Journal of Biological Chemistry.
283:8412-8422.
2008
|
|
| 2008
|
Chromatin immunoprecipitation assays: Application of chip-on-chip for defining dynamic transcriptional mechanisms in bone cells.
Methods in Molecular Biology.
455:165-176.
2008
|
|
| 2008
|
In situ nuclear organization of regulatory machinery.
Methods in Molecular Biology.
455:239-259.
2008
|
|
| 2007
|
Growth inhibition of osteoblast progenitors by Runx2 depends on its C-terminal regulatory domain and is accompanied by changes in G-Protein coupled signaling pathways.
Journal of Bone and Mineral Research.
22:S94-S94.
2007
|
|
| 2007
|
Nuclear microenvironments in biological control and cancer.
Nature Reviews Cancer.
7:454-463.
2007
|
|
| 2007
|
Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2
2007
|
|
| 2007
|
Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation.
Journal of Cellular Biochemistry.
100:434-449.
2007
|
|
| 2007
|
Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2.
Nature.
445:442-446.
2007
|
|
| 2007
|
Organization of transcriptional regulatory machinery in nuclear microenvironments: Implications for biological control and cancer.
Advances in Enzyme Regulation.
47:242-250.
2007
|
|
| 2006
|
BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network.
Journal of Biological Chemistry.
281:40515-40526.
2006
|
|
| 2006
|
BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network.
Journal of Biological Chemistry.
281:40515-40526.
2006
|
|
| 2006
|
Alterations in intranuclear localization of Runx2 affect biological activity.
Journal of Cellular Physiology.
209:935-942.
2006
|
|
| 2006
|
Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone.
Cancer and Metastasis Reviews.
25:589-600.
2006
|
|
| 2006
|
Defects in intranuclear localization of Runx2 alter osteoblast differentiation ex vivo..
Journal of Bone and Mineral Research.
21:S155-S155.
2006
|
|
| 2006
|
Mitotic retention of the bone phenotype by the cell fate determining transcription factor Runx2..
Journal of Bone and Mineral Research.
21:S378-S378.
2006
|
|
| 2006
|
Post-mitotic expression of transcription factor RUNX2 defines a novel regulatory transition during the G1 phase of proliferating Pre-Osteoblasts..
Journal of Bone and Mineral Research.
21:S384-S384.
2006
|
|
| 2006
|
Specific residues of Runx2/Cbfa1 direct Osteoblast differentiation and integration of BMP2 osteogenic signal..
Journal of Bone and Mineral Research.
21:S381-S381.
2006
|
|
| 2006
|
Networks and hubs for the transcriptional control of osteoblastogenesis.
Reviews in Endocrine and Metabolic Disorders.
7:1-16.
2006
|
|
| 2006
|
Microtubule-dependent nuclear-cytoplasmic shuttling of Runx2.
Journal of Cellular Physiology.
206:354-362.
2006
|
|
| 2006
|
Organization of transcriptional regulatory machinery in nuclear microenvironments: Implications for biological control and cancer.
Cancer Treatment Reviews.
32:S13-S13.
2006
|
|
| 2005
|
Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
Journal of Cellular Biochemistry.
96:795-809.
2005
|
|
| 2005
|
The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion.
Molecular and Cellular Biology.
25:8581-8591.
2005
|
|
| 2005
|
Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression.
Journal of Biological Chemistry.
280:33132-33140.
2005
|
|
| 2005
|
A critical point mutation in the Runx2 subnuclear targeting domain abrogates osteogenic function by blocking integration of the BMP2 signal.
Journal of Bone and Mineral Research.
20:S9-S9.
2005
|
|
| 2005
|
Msx2 antagonizes Runx2 regulation of osteolytic activity in breast cancer cells..
Journal of Bone and Mineral Research.
20:S327-S327.
2005
|
|
| 2005
|
Organization of transcriptional regulatory machinery in osteoclast nuclei: Compartmentalization of Runx1.
Journal of Cellular Physiology.
204:871-880.
2005
|
|
| 2005
|
Reconstitution of Runx2/Cbfa1null cells identifies Runx2 domains required for osteoblast differentiation.
Journal of Bone and Mineral Research.
20:S5-S5.
2005
|
|
| 2005
|
Runx2 association with microtubules: A potential role in nucleo-cytoplasmic shuttling..
Journal of Bone and Mineral Research.
20:S78-S78.
2005
|
|
| 2005
|
The Runx2 transcription factor supports expression of genes coupled to the invasive and osteolytic properties of breast cancer cells..
Journal of Bone and Mineral Research.
20:S328-S328.
2005
|
|
| 2005
|
Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription.
Journal of Cellular Physiology.
204:63-72.
2005
|
|
| 2005
|
The dynamic organization of gene-regulatory machinery in nuclear microenvironments.
EMBO Reports.
6:128-133.
2005
|
|
| 2005
|
SWI/SNF chromatin remodeling complex is obligatory for BMP2-induced, Runx2-dependent skeletal gene expression that controls osteoblast differentiation.
Journal of Cellular Biochemistry.
94:720-730.
2005
|
|
| 2005
|
Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo
2005
|
|
| 2005
|
Combinatorial organization of the transcriptional regulatory machinery in biological control and cancer.
Advances in Enzyme Regulation.
45:136-154.
2005
|
|
| 2005
|
Contributions of nuclear structure-function relationships to the onset and progression of tumorigenesis.
Journal of Bone and Mineral Research.
20:P7-P7.
2005
|
|
| 2005
|
Runx2 regulates tumor cell invasive properties and contributes to the osteolytic bone disease associated with metastatic cancer cells.
Journal of Bone and Mineral Research.
20:P16-P16.
2005
|
|
| 2005
|
Runx2/Msx2 interactions regulating breast cancer-induced osteolysis in bone.
Journal of Bone and Mineral Research.
20:P33-P33.
2005
|
|
| 2004
|
Nuclear microenvironments support assembly and organization of the transcriptional regulatory machinery for cell proliferation and differentiation.
Journal of Cellular Biochemistry.
91:287-302.
2004
|
|
| 2004
|
Active retention of phenotype during cell division: Runx (AML/Cbfa) transcription factors are bound to gene promoters within the condensed mitotic chromosomes
2004
|
|
| 2004
|
Intranuclear trafficking: Organization and assembly of regulatory machinery for combinatorial biological control.
Journal of Biological Chemistry.
279:43363-43366.
2004
|
|
| 2004
|
The vitamin D response element in the distal osteocalcin promoter contributes to chromatin organization of the proximal regulatory domain.
Journal of Biological Chemistry.
279:43581-43588.
2004
|
|
| 2004
|
Convergence of BMP2/TGF beta MAPK and Runx2 signaling in subnuclear foci during osteogenic lineage induction.
Journal of Bone and Mineral Research.
19:S46-S46.
2004
|
|
| 2004
|
Dlx3 is a transcriptional regulator of osteoblast differentiation and increases expression and promoter activity of Runx2..
Journal of Bone and Mineral Research.
19:S37-S37.
2004
|
|
| 2004
|
Dlx3 transcriptional regulation of osteoblast differentiation: Temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene.
Molecular and Cellular Biology.
24:9248-9261.
2004
|
|
| 2004
|
Establishment of a mechanistic link between the osteogenic function of Runx2 and its sulnuclear organization by intranuclear informatics..
Journal of Bone and Mineral Research.
19:S144-S144.
2004
|
|
| 2004
|
Expression pattern of core binding factor-beta in skeletal tissues.
Journal of Bone and Mineral Research.
19:S400-S400.
2004
|
|
| 2004
|
Multiple nuclei in osteoclasts functionally compartmentalize gene regulatory machinery.
Journal of Bone and Mineral Research.
19:S280-S281.
2004
|
|
| 2004
|
Quantitative signature for architectural organization of regulatory factors using intranuclear informatics.
Journal of Cell Science.
117:4889-4896.
2004
|
|
| 2004
|
Wnt signaling regulates Runx2 expression in vivo and activates the bone-related Runx2 P1 promoter.
Journal of Bone and Mineral Research.
19:S56-S56.
2004
|
|
| 2004
|
Ectopic Runx2 regulates breast cancer metastasis-associated osteolytic disease.
Journal of Bone and Mineral Research.
19:1578-1578.
2004
|
|
| 2004
|
Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease.
Cancer Research.
64:4506-4513.
2004
|
|
| 2004
|
Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression.
Oncogene.
23:4315-4329.
2004
|
|
| 2004
|
Nuclear microenvironments: An architectural platform for the convergence and integration of transcriptional regulatory signals.
European Journal of Histochemistry.
48:65-76.
2004
|
|
| 2004
|
Analysis of in vivo gene expression using epitope-tagged proteins..
Methods in Molecular Biology.
285:37-40.
2004
|
|
| 2004
|
Chromatin immunoprecipitation..
Methods in Molecular Biology.
285:41-44.
2004
|
|
| 2004
|
Immunofluorescence analysis using epitope-tagged proteins: in vitro system..
Methods in Molecular Biology.
285:33-36.
2004
|
|
| 2004
|
In situ immunofluorescence analysis: analyzing RNA synthesis by 5-bromouridine-5'-triphosphate labeling..
Methods in Molecular Biology.
285:29-31.
2004
|
|
| 2004
|
In situ immunofluorescence analysis: immunofluorescence microscopy..
Methods in Molecular Biology.
285:23-28.
2004
|
|
| 2004
|
PLURIPOTENCY OF ADULT STEM CELLS: INSTRUCTIONS FOR OSTEOGENIC LINEAGE DIRECTION.
Calcified Tissue International.
74:S25-S25.
2004
|
|
| 2004
|
Protein-deoxyribonucleic acid interactions linked to gene expression: DNase I digestion..
Methods in Molecular Biology.
285:57-62.
2004
|
|
| 2004
|
Protein-deoxyribonucleic acid interactions linked to gene expression: electrophoretic mobility shift assay..
Methods in Molecular Biology.
285:45-55.
2004
|
|
| 2004
|
Protein-deoxyribonucleic acid interactions linked to gene expression: ligation-mediated polymerase chain reaction..
Methods in Molecular Biology.
285:63-67.
2004
|
|
| 2004
|
Regulatory Controls for Osteoblast Growth and Differentiation: Role of Runx/Cbfa/AML Factors.
Critical Reviews in Eukaryotic Gene Expression.
14:1-41.
2004
|
|
| 2003
|
Mitotic partitioning and selective reorganization of tissue-specific transcription factors in progeny cells
2003
|
|
| 2003
|
Mitotic partitioning and selective reorganization of tissue-specific transcription factors in progeny cells
2003
|
|
| 2003
|
Nuclear microenvironments support physiological control of gene expression
2003
|
|
| 2003
|
Chromatin remodeling of the proximal rat osteocalcin promoter is dependent on vitamin D receptor binding at the distal promoter element.
Journal of Bone and Mineral Research.
18:S225-S225.
2003
|
|
| 2003
|
Ectopic runx2 regulates breast cancer metastasis associated osteolytic disease.
Journal of Bone and Mineral Research.
18:S26-S26.
2003
|
|
| 2003
|
Subnuclear targeting supports functional interrelationships between Runx2 and the BMP-2 regulated Smad 1 protein.
Journal of Bone and Mineral Research.
18:S6-S7.
2003
|
|
| 2003
|
Runx1/AML1 hematopoietic transcription factor contributes to skeletal development in vivo.
Journal of Cellular Physiology.
196:301-311.
2003
|
|
| 2003
|
Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells.
Cancer Research.
63:2631-2637.
2003
|
|
| 2003
|
Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity.
Molecular and Cellular Biology.
23:3339-3351.
2003
|
|
| 2003
|
Intranuclear trafficking of transcription factors: Requirements for vitamin D-mediated biological control of gene expression.
Journal of Cellular Biochemistry.
88:340-355.
2003
|
|
| 2003
|
Functional architecture of the nucleus: Organizing the regulatory machinery for gene expression, replication and repair.
Trends in Cell Biology.
13:584-592.
2003
|
|
| 2003
|
Intranuclear organization of RUNX transcriptional regulatory machinery in biological control of skeletogenesis and cancer.
Blood Cells, Molecules and Diseases.
30:170-176.
2003
|
|
| 2003
|
Runx2/Cbfa1 functions: Diverse regulation of gene transcription by chromatin remodeling and co-regulatory protein interactions.
Connective Tissue Research.
44:141-148.
2003
|
|
| 2002
|
Cbfβ interacts with RUNX2 and has a critical role in bone development.
Nature Genetics.
32:639-644.
2002
|
|
| 2002
|
Transcription factors RUNX1/AML1 and RUNX2/Cbfa1 dynamically associate with stationary subnuclear domains.
Journal of Cell Science.
115:4167-4176.
2002
|
|
| 2002
|
Transcription factors RUNX1/AML1 and RUNX2/Cbfa1 dynamically associate with stationary subnuclear domains.
Journal of Cell Science.
115:4167-4176.
2002
|
|
| 2002
|
Cbfb, a well-known, regulator of hematopoiesis, cooperates with Cbfa1 and plays a critical role in bone development..
Journal of Bone and Mineral Research.
17:S126-S126.
2002
|
|
| 2002
|
Runx factors are expressed in the osteoclast and regulated during osteoclast differentiation..
Journal of Bone and Mineral Research.
17:S452-S452.
2002
|
|
| 2002
|
Runx1(Cbfa2/AML1) is expressed in tissues supporting osteogenesis and temporally regulated during chondrocyte and osteoblast differentiation..
Journal of Bone and Mineral Research.
17:S151-S151.
2002
|
|
| 2002
|
CCAAT/enhancer-binding proteins (C/EBP) β and δ activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression.
Journal of Biological Chemistry.
277:1316-1323.
2002
|
|
| 2001
|
Runx2-C/EBP molecular interactions and functional synergism support maximal expression of osteocalcin in osteoblasts
2001
|
|
| 2001
|
Trafficking of Runx1/Cbfa2 and Runx2/Cbfa1 in living cells defines a dynamic subnuclear domain
2001
|
|
| 2001
|
A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene.
Journal of Cell Science.
114:3093-3102.
2001
|
|
| 2001
|
A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene..
Journal of Cell Science.
114:3093-3102.
2001
|
|
| 2001
|
Developmental utilization of distinct promoters regulating the type I and type II isoforms of the bone Runx2/Cbfa1 transcription factor..
Journal of Bone and Mineral Research.
16:S205-S205.
2001
|
|
| 2001
|
Differential Regulation of the Two Principal Runx2/Cbfa1 N-Terminal Isoforms in Response to Bone Morphogenetic Protein-2 during Development of the Osteoblast Phenotype.
Endocrinology.
142:4026-4039.
2001
|
|
| 2001
|
Forced expression of Runx2/Cbfa1 driven by the -3.6 kb Collagen Type I promoter results in a normal phenotype in transgenic mice..
Journal of Bone and Mineral Research.
16:S446-S446.
2001
|
|
| 2001
|
Runx2-C/EBP molecular interactions and functional synergism support maximal expression of osteocalcin in osteoblasts..
Journal of Bone and Mineral Research.
16:S175-S175.
2001
|
|
| 2001
|
Trafficking of Runx1/Cbfa2 and Runx2/Cbfa1 in living cells defines a dynamic subnuclear domain..
Journal of Bone and Mineral Research.
16:S488-S488.
2001
|
|
| 2001
|
Subnuclear targeting of Runx/CBFa/AML factors is essential for tissue-specific differentiation during embryonic development
2001
|
|
| 2001
|
Contributions of nuclear architecture and chromatin to vitamin D-dependent transcriptional control of the rat osteocalcin gene.
Steroids.
66:159-170.
2001
|
|
| 2001
|
Runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: Evidence for promoter context-dependent activity of Cbfa proteins.
Molecular and Cellular Biology.
21:2891-2905.
2001
|
|
| 2001
|
Expression and regulation of RUNX2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts.
Journal of Cellular Biochemistry.
80:424-440.
2001
|
|
| 2001
|
Differential regulation of the two principal Runx2/Cbfa1 N-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype.
Endocrinology.
142:4026-4039.
2001
|
|
| 2000
|
Intranuclear trafficking of RUNX2/Cbfa1 and RUNX1/AML1 in living cells
2000
|
|
| 2000
|
Nuclear matrix proteins as cancer markers.
Journal of Cellular Biochemistry.
80:136-141.
2000
|
|
| 2000
|
C/EBP is a potent activator of osteocalcin gene transcription..
Journal of Bone and Mineral Research.
15:S497-S497.
2000
|
|
| 2000
|
In vivo replacement of the Runx2/Cbfa1 gene with a mutant gene lacking a subnuclear targeting signal and transcriptional regulatory functions results in severe skeletal abnormalities..
Journal of Bone and Mineral Research.
15:S157-S157.
2000
|
|
| 2000
|
RUNX (CBFalpha/AML/PEBP2alpha) dependent repression of tissue-specific gene transcription involves in situ association with Groucho/TLE/R-esp proteins..
Journal of Bone and Mineral Research.
15:S498-S498.
2000
|
|
| 2000
|
Intranuclear trafficking of transcription factors: Implications for biological control.
Journal of Cell Science.
113:2527-2533.
2000
|
|
| 2000
|
Leukemia-associated AML1/ETO (8;21) chromosomal translocation protein increases the cellular representation of PML bodies..
Journal of Cellular Biochemistry.
79:103-112.
2000
|
|
| 2000
|
Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBFα/AML/PEBP2α) dependent activation of tissue-specific gene transcription.
Journal of Cell Science.
113:2221-2231.
2000
|
|
| 2000
|
Subnuclear organization and trafficking of regulatory proteins: implications for biological control and cancer.
2000
|
|
| 1999
|
The CCAAT displacement protein/cut homeodomain protein represses osteocalcin gene transcription and forms complexes with the retinoblastoma protein-related protein p107 and cyclin A.
Cancer Research.
59:5980-5988.
1999
|
|
| 1999
|
Insight into regulatory factor targeting to transcriptionally active subnuclear sites.
Experimental Cell Research.
253:110-116.
1999
|
|
| 1999
|
Crystal structure of the nuclear matrix targeting signal of the transcription factor acute myelogenous leukemia-1/polyoma enhancer-binding protein 2αB/core binding factor α2.
Journal of Biological Chemistry.
274:33580-33586.
1999
|
|
| 1999
|
Contributions of chromatin structure to bone tissue-specific transcription.
1999
|
|
| 1999
|
Structure-function determinants for subnuclear targeting nod transactivation in the Cbfa1/AML3 transcription factor.
1999
|
|
| 1999
|
C/EBP family members are expressed in osteoblast and are involved in regulation of osteocalcin gene transcription..
Journal of Bone and Mineral Research.
14:S469-S469.
1999
|
|
| 1999
|
Cbfa family members act as a negative regulator of the bone sialoprotein gene..
Journal of Bone and Mineral Research.
14:S165-S165.
1999
|
|
| 1999
|
Contributions of nuclear architecture to bone-specific and steroid hormone regulation of osteocalcin gene transcription..
Journal of Bone and Mineral Research.
14:S454-S454.
1999
|
|
| 1999
|
Structure-function determinants for subnuclear targeting and transactivation in the Cbfa1/AML3 transcription factor..
Journal of Bone and Mineral Research.
14:S469-S469.
1999
|
|
| 1999
|
The C-terminus of CBFA1 supports subnuclear trafficking of green fluorescent protein tagged-CBFA1..
Journal of Bone and Mineral Research.
14:S553-S553.
1999
|
|
| 1999
|
Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor β1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
Journal of Cellular Biochemistry.
73:114-125.
1999
|
|
| 1999
|
Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D-responsive transcription and contribute to chromatin organization.
Molecular and Cellular Biology.
19:7491-7500.
1999
|
|
| 1998
|
CBFa(AML/PEBP2)-related elements in the TGF-β type I receptor promoter and expression with osteoblast differentiation.
Journal of Cellular Biochemistry.
69:353-363.
1998
|
|
